Silo Pharma Files 8-K
Ticker: SILO · Form: 8-K · Filed: Mar 7, 2025 · CIK: 1514183
| Field | Detail |
|---|---|
| Company | Silo Pharma, Inc. (SILO) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Silo Pharma filed an 8-K on March 7th, updating on corporate events and financials.
AI Summary
Silo Pharma, Inc. filed an 8-K on March 7, 2025, reporting other events and financial statements as of March 4, 2025. The company, formerly known as Uppercut Brands, Inc., is incorporated in Nevada and has its principal executive offices in Sarasota, Florida.
Why It Matters
This filing provides an update on Silo Pharma's corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events but does not inherently indicate high risk.
Key Players & Entities
- Silo Pharma, Inc. (company) — Registrant
- March 4, 2025 (date) — Earliest event reported
- March 7, 2025 (date) — Filing date
- Uppercut Brands, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Sarasota, FL (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Silo Pharma, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 4, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on March 7, 2025.
What was Silo Pharma, Inc. formerly known as?
Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc., with previous name changes also noted from Point Capital, Inc. and Gold Swap Inc.
In which state is Silo Pharma, Inc. incorporated?
Silo Pharma, Inc. is incorporated in Nevada.
What is the address of Silo Pharma, Inc.'s principal executive offices?
The principal executive offices of Silo Pharma, Inc. are located at 677 N. Washington Boulevard, Sarasota, FL 34236.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 7, 2025 regarding Silo Pharma, Inc. (SILO).